Yttrium (90Y) tacatuzumab tetraxetan

Yttrium (90Y) tacatuzumab tetraxetan?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target α-fetoprotein
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 500784-58-7 Y
ATC code None
Chemical data
Formula C6470H9971N1712O2007S4290Y
Mol. mass 145 kDa
 N(what is this?)  (verify)

Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Counil
  2. ^ WHO Drug Information
Tumor ("-t(u[m])-")
Human ("-tumu-")
Mouse ("-tumo-")
Chimeric ("-tuxi-")
Humanized ("-tuzu-")
Rat/mouse hybrid ("-tumaxo-")